市場調査レポート

商品コード

1593515

組み換えタンパク質の市場規模・シェア・成長分析 (製品別、用途別、地域別)：産業予測 (2024～2031年)

Recombinant Protein Market Size, Share, Growth Analysis, By Product (Cytokines & Growth Factors, Antibodies), By Application (Drug Discovery & Development, Biopharmaceutical Production), By Region - Industry Forecast 2024-2031

出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

組み換えタンパク質の世界市場規模は、2022年に約22億米ドルと評価され、2023年の23億6,000万米ドルから上昇し、予測期間 (2024-2031年) のCAGRは7.2%で、2031年には41億1,000万米ドルに達すると予測されています。

世界の組み換えタンパク質市場は、2023年から2030年にかけて大幅なCAGR (複合年間成長率) で成長すると予測されます。この急成長は遺伝子技術の進歩 (コーディング配列の単離、その配列の発現プラスミドベクターへのクローニングなど) によってもたらされます。治療用組み換えタンパク質の大部分は、微生物・酵母・動物の細胞培養を用いて合成され、タンパク質間相互作用の研究に不可欠です。組み換えタンパク質の汎用性は、洗剤、美容製品、食品サプリメント、食品製造、診断、ワクチン、治療など、様々な用途に広がっています。市場拡大の要因としては、医療機関による研究開発への投資の増加、慢性疾患の流行、ウイルス感染対策を目的とした規制措置の重視の高まりなどが挙げられます。このような研究開発への投資と革新的な治療ソリューションへの需要が合流することで、市場情勢は力強い成長を遂げ、バイオテクノロジーと医療の進化を活かそうとする利害関係者に大きな機会を提供しています。市場の成熟が進むにつれて、製品ラインナップの充実、生産プロセスの改善、応用範囲の拡大が期待され、組み換えタンパク質が科学研究と治療開発の双方において極めて重要な役割を果たしていることが明らかになるでしょう。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (MEA)
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア (2023年)

主要企業プロファイル

Bio-Techne (米国)
Thermo Fisher Scientific Inc. (米国)
Merck KGaA (ドイツ)
Danaher Corporation (米国)
Abnova Corporation (台湾)
BioLegend Inc (米国)
Bio-Rad Laboratories, Inc. (米国)
BPS Bioscience, Inc. (米国)
Enzo Biochem Inc. (米国)
GenScript (中国)
Miltenyi Biotec B.V. & Co. KG (ドイツ)
Proteintech Group, Inc. (米国)
Sino Biological Inc. (中国)
ACROBiosystems Group (米国)
Aviva Systems Biology Corporation (米国)
Sartorius CellGenix GmbH (ドイツ)
Icosagen (米国)
Neuromics (米国)
ProSpec-Tany TechnoGene Ltd. (イスラエル)
ProteoGenix S.A.S (フランス)

Product Code: SQMIG35H2039

Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024-2031).

The global recombinant protein market is anticipated to experience significant growth at a strong compound annual growth rate (CAGR) from 2023 to 2030. This surge is driven by advancements in genetic techniques, including the isolation of coding sequences and the cloning of these sequences into expression plasmid vectors. A majority of therapeutic recombinant proteins are synthesized using microbial, yeast, or animal cell cultures, which are essential for investigating protein-protein interactions. The versatility of recombinant proteins extends across various applications, including detergents, beauty products, food supplements, food manufacturing, diagnostics, vaccines, and therapies. Contributing factors to the market's expansion include increasing investments by healthcare organizations into research and development, a rising prevalence of chronic diseases, and a growing emphasis on regulatory measures aimed at combatting viral infections. This confluence of investments in R&D and the demand for innovative therapeutic solutions positions the recombinant protein market for robust growth and offers significant opportunities for stakeholders aiming to capitalize on the evolving landscape of biotechnology and healthcare. As the market continues to mature, we can expect to see enhanced product offerings, improved production processes, and a broader range of applications, underscoring the pivotal role recombinant proteins play in both scientific research and therapeutic development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Recombinant Proteins market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Recombinant Proteins Market Segmental Analysis

Global Recombinant Proteins Market is segmented by Product, Application, Host cell, End User and region. Based on Product, the market is segmented into Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Proteins, Hormones, Others. Based on Application, the market is segmented into Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Biopharmaceutical Production, Research (Academic Research, Biotechnology Research), Diagnostics, and Others. Based on Host cell, the market is segmented into Mammalian Systems, Insect Cells, Yeast & Fungi, Bacterial Cells, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical, Academic Research Institutes, Contract Research Organizations, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Recombinant Proteins Market

The Global Recombinant Proteins market is propelled by rising R&D expenditures and increased funding within pharmaceutical and biotechnological sectors, leading to significant advancements in drug development. The heightened emphasis on regulatory compliance has expanded treatment options for rare diseases, such as hemophilia and bleeding disorders, further fueling market growth. The escalating demand for biopharmaceuticals is largely attributed to recombinant proteins, which offer enhanced potency, specificity, and reduced side effects compared to conventional small molecule therapies. Consequently, these factors are catalyzing the development of recombinant protein drugs targeting a diverse array of illnesses, including autoimmune disorders, infectious diseases, and cancer.

Restraints in the Global Recombinant Proteins Market

The Global Recombinant Proteins market faces significant restraints due to intense price competition resulting from an influx of key players introducing similar products in a limited market. This saturation leads to decreasing prices, which, while benefiting consumers, undermines profitability and hampers market growth. Additionally, the sector grapples with a shortage of trained medical professionals proficient in recombinant protein applications and research. This skill gap restricts innovation, development, and the effective utilization of recombinant technologies, further stifling industrial advancement. Together, these factors constrain the market's potential and hinder its ability to reach broader applications and increased revenue streams.

Market Trends of the Global Recombinant Proteins Market

The Global Recombinant Proteins market is witnessing robust growth, particularly within the antibody segment, which is anticipated to expand exponentially due to increased adoption across diverse applications such as therapeutics, diagnostics, and research. This trend is driven by advancements in biotechnology, enabling companies to efficiently identify and produce high-quality antibodies through optimized selection processes and expression systems. The rising demand for monoclonal antibodies in personalized medicine, along with a growing focus on biopharmaceuticals, is further propelling market expansion. As industries seek innovative solutions to healthcare challenges, recombinant proteins are becoming vital assets, solidifying their role in modern medicine and research.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Value Chain Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Analysis
PESTEL Analysis

Recombinant Proteins Market, By Product

Market Overview
Cytokines & Growth Factors
- Interferons (IFNs)
- Interleukins (ILs)
- Others
Antibodies
Immune Checkpoint Proteins
Virus Antigens
Enzymes
- Kinases
- Metabolic Enzymes
- Others
Recombinant Regulatory Proteins
Hormones
Others

Recombinant Proteins Market, By Application

Market Overview
Drug Discovery & Development
- Biologics
- Vaccines
- Cell & Gene Therapy
Research
- Academic Research
- Biotechnology Research
Biopharmaceutical Production
Diagnostics
Other Applications

Recombinant Proteins Market, By Host Cell

Market Overview
Mammalian Systems
Insect Cells
Yeast & Fungi
Bacterial Cells
Other Host Cells

Recombinant Proteins Market, By End User

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Other End Users

Recombinant Proteins Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend Inc (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BPS Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec B.V. & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteintech Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Biological Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACROBiosystems Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aviva Systems Biology Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius CellGenix GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icosagen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuromics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProSpec-Tany TechnoGene Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProteoGenix S.A.S (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

組み換えタンパク質の市場規模・シェア・成長分析 (製品別、用途別、地域別)：産業予測 (2024～2031年)

Recombinant Protein Market Size, Share, Growth Analysis, By Product (Cytokines & Growth Factors, Antibodies), By Application (Drug Discovery & Development, Biopharmaceutical Production), By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

組み換えタンパク質市場：製品別

組み換えタンパク質市場：用途別

組み換えタンパク質市場：宿主細胞別

組み換えタンパク質市場：エンドユーザー別

組み換えタンパク質の市場規模：地域別